Searches both Title and Fulltext content
Takes you to the requested Key Event
Clear Search Terms Clears search terms and filters

Showing 301 to 325 of 1959 Key Events

Clear Table Filters
ID Title Event Component Count Biological Organization Created At Last Updated AOPs
2163 Activation Sema6A
0 Cellular Aug 20, 2023 Aug 20, 2023 508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
2162 Activation, HIF1α
0 Cellular Aug 20, 2023 Aug 20, 2023 508: Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway
2161 Increase, Vascular disrupting effects
0 Individual Aug 19, 2023 Aug 19, 2023
2160 Angiogenesis disfunction
0 Organ Aug 19, 2023 Aug 19, 2023 None
2159 Influenza A virus (IAV) cell entry
3 Cellular Aug 11, 2023 Oct 3, 2023 506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
2158 Influenza A Virus (IAV) binds sialic acid glycan receptor
1 Molecular Jul 31, 2023 Aug 2, 2023 506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
2157 Abnormal Cardiac Structure and Function
0 Organ Jul 31, 2023 Jul 31, 2023 557: β2-Receptor agonist leading to Cardiomyopathy
2156 Increased morbidity of congenital heart defect
0 Population Jul 31, 2023 Jul 31, 2023 None
2155 Inhibition of Sulfotransferase E1 (SULT1E1)
1 Molecular Jul 28, 2023 Feb 21, 2025 504: SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level
2154 Uterine adenocarcinoma (endometrioid adenocarcinoma Type I)
0 Organ Jul 27, 2023 Mar 6, 2025 503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
2153 Expression of factors ruling proliferation, modified
0 Cellular Jul 27, 2023 Apr 28, 2025 503: Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation
2152 Epigenetic modification process
0 Cellular Jul 27, 2023 Jul 28, 2026
2151 Disruption, neurotransmitter release
1 Molecular Jun 27, 2023 Jul 21, 2023
2150 Neurological disorder
0 Individual Jun 15, 2023 Jun 15, 2023
2149 Increased intracelluar Iron accumulation
0 Cellular Jun 15, 2023 Jun 15, 2023
2148 Increased LCN2/iron complex binds to SLC22A17 receptor in neuron
0 Molecular Jun 15, 2023 Jun 15, 2023 498: Increased LCN2/iron complex leading to neurological disorders
2147 Decreased, Viable Offspring
2 Individual Jun 2, 2023 Apr 10, 2024
2146 Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
1 Molecular May 25, 2023 Jul 28, 2023
2145 Metabolic syndrome
0 Population May 25, 2023 May 25, 2023 497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
2144 Impaired insulin signaling
0 Cellular May 25, 2023 May 25, 2023 497: ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
2142 Depletion, Ectoplasmic specialization (ES)
0 Cellular May 17, 2023 May 17, 2023 476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
2141 Disruption, Estrogen receptor
0 Molecular May 17, 2023 May 17, 2023 476: Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
2140 Decreased spawning and cumulative fecundity, decreased gonadosomatic index
0 Individual May 16, 2023 May 16, 2023 None
2139 Reduction, the ratio of 17beta-estradiol/11-Keto Testosterone in plasma
0 Organ May 16, 2023 May 16, 2023 496: Androgen receptor agonism leading to reproduction dysfunction (in zebrafish)
2137 Increase, Gonadotropins concentration in plasma
1 Cellular May 16, 2023 Apr 6, 2026